|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
2 National Institutes of Health, Bethesda, MD, USA
3 Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom
* To whom correspondence should be addressed. E-mail: lawrence.young{at}yale.edu.
AMPK is a serine-threonine kinase which regulates cellular metabolism and has an
essential role in activating glucose transport during hypoxia and ischemia. The mechanisms
responsible for AMPK stimulation of glucose transport are uncertain, but may involve
interaction with other signaling pathways or direct effects on glucose transporter (GLUT)
vesicular trafficking. One potential downstream mediator of AMPK signaling is the nitric
oxide pathway. The aim of this study was to examine the extent to which AMPK mediates
glucose transport through activation of the nitric oxide signaling pathway in isolated heart
muscles. Incubation with 1 mM 5-amino-4-imidazolecarboxamide ribofuranoside
(AICAR) activated AMPK (P<0.01), stimulated glucose uptake (P<0.05) and translocation
of the cardiomyocyte glucose transporter GLUT4 to the cell surface (P<0.05). AICAR
treatment increased phosphorylation of endothelial nitric oxide synthase (eNOS) by ~1.8-
fold (P<0.05). eNOS, but not nNOS, co-immunoprecipitated with both the
2 and
1
AMPK catalytic subunits in heart muscle. Nitric oxide donors also increased glucose
uptake and GLUT 4 translocation (P<0.05). Inhibition of NOS with L-NAME and LNMMA,
reduced AICAR-stimulated glucose uptake by 21 ± 3% (P<0.05) and 25 ± 4%
(P<0.05) respectively. Inhibition of guanylate cyclase with ODQ and LY83583, reduced
AICAR-stimulated glucose uptake by 31 ± 4% (P<0.05) and 22 ± 3% (P<0.05)
respectively, as well as GLUT4 translocation to the cell surface (P<0.05). Taken together,
these results indicate that activation of the nitric oxide/guanylate cyclase pathway contributes
to, but is not the sole mediator of AMPK-stimulation of glucose uptake and GLUT4
translocation in heart muscle.
This article has been cited by other articles:
![]() |
N. Bashan, J. Kovsan, I. Kachko, H. Ovadia, and A. Rudich Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species Physiol Rev, January 1, 2009; 89(1): 27 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Erusalimsky and S. Moncada Nitric Oxide and Mitochondrial Signaling: From Physiology to Pathophysiology Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2524 - 2531. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Miller, J. Li, K. M. Sinusas, G. D. Holman, and L. H. Young Infusion of a biotinylated bis-glucose photolabel: a new method to quantify cell surface GLUT4 in the intact mouse heart Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1922 - E1928. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koneru, S. V. Penumathsa, M. Thirunavukkarasu, S. M. Samuel, L. Zhan, Z. Han, G. Maulik, D. K. Das, and N. Maulik Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4 Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2060 - H2072. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arad, C. E. Seidman, and J.G. Seidman AMP-Activated Protein Kinase in the Heart: Role During Health and Disease Circ. Res., March 2, 2007; 100(4): 474 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Dolinsky and J. R. B. Dyck Role of AMP-activated protein kinase in healthy and diseased hearts Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2557 - H2569. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fujii, N. Jessen, and L. J. Goodyear AMP-activated protein kinase and the regulation of glucose transport Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E867 - E877. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. An and B. Rodrigues Role of changes in cardiac metabolism in development of diabetic cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Saunders, S. L. Xenophontos, M. A. Cariolou, L. C. Anastassiades, T. D. Noakes, and M. Collins The bradykinin {beta}2 receptor (BDKRB2) and endothelial nitric oxide synthase 3 (NOS3) genes and endurance performance during Ironman Triathlons Hum. Mol. Genet., March 15, 2006; 15(6): 979 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Mount, R. E. Hill, S. A. Fraser, V. Levidiotis, F. Katsis, B. E. Kemp, and D. A. Power Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOS-Ser1177 Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1103 - F1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, E. J. Miller, J. Ninomiya-Tsuji, R. R. Russell III, and L. H. Young AMP-Activated Protein Kinase Activates p38 Mitogen-Activated Protein Kinase by Increasing Recruitment of p38 MAPK to TAB1 in the Ischemic Heart Circ. Res., October 28, 2005; 97(9): 872 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liao, S. Takashima, N. Maeda, N. Ouchi, K. Komamura, I. Shimomura, M. Hori, Y. Matsuzawa, T. Funahashi, and M. Kitakaze Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism Cardiovasc Res, September 1, 2005; 67(4): 705 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart Physiol Rev, July 1, 2005; 85(3): 1093 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Flogel, T. Laussmann, A. Godecke, N. Abanador, M. Schafers, C. D. Fingas, S. Metzger, B. Levkau, C. Jacoby, and J. Schrader Lack of Myoglobin Causes a Switch in Cardiac Substrate Selection Circ. Res., April 29, 2005; 96(8): e68 - e75. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang and G. D. Holman Insulin and Contraction Stimulate Exocytosis, but Increased AMP-activated Protein Kinase Activity Resulting from Oxidative Metabolism Stress Slows Endocytosis of GLUT4 in Cardiomyocytes J. Biol. Chem., February 11, 2005; 280(6): 4070 - 4078. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |